Ho Yun Lee Selected Research

Immune Checkpoint Inhibitors

1/2021	A Wake-Up Call for Immune Checkpoint Inhibitor-Related Pneumonitis.
1/2021	Chest CT Diagnosis and Clinical Management of Drug-related Pneumonitis in Patients Receiving Molecular Targeting Agents and Immune Checkpoint Inhibitors: A Position Paper from the Fleischner Society.
1/2021	Chest CT Diagnosis and Clinical Management of Drug-Related Pneumonitis in Patients Receiving Molecular Targeting Agents and Immune Checkpoint Inhibitors: A Position Paper From the Fleischner Society.
11/2019	Improved treatment outcome of pembrolizumab in patients with nonsmall cell lung cancer and chronic obstructive pulmonary disease.
1/2019	Comprehensive Clinical and Genetic Characterization of Hyperprogression Based on Volumetry in Advanced Non-Small Cell Lung Cancer Treated With Immune Checkpoint Inhibitor.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Ho Yun Lee Research Topics

Disease

36	Neoplasms (Cancer) 11/2022 - 04/2010
18	Adenocarcinoma of Lung 08/2021 - 05/2011
15	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 07/2022 - 04/2010
9	Lung Neoplasms (Lung Cancer) 07/2022 - 12/2012
5	Neoplasm Metastasis (Metastasis) 01/2022 - 07/2012
5	Infections 05/2021 - 10/2013
5	Adenocarcinoma 11/2020 - 04/2012
4	Sensorineural Hearing Loss 10/2021 - 01/2014
4	Pneumonia (Pneumonitis) 01/2021 - 12/2013
4	Emphysema 06/2020 - 02/2013
4	Tinnitus 01/2019 - 06/2013
4	Otitis Media with Effusion 04/2017 - 10/2013
3	Interstitial Lung Diseases (Interstitial Lung Disease) 01/2022 - 11/2011
3	Pain (Aches) 05/2021 - 08/2007
3	Facial Paralysis (Facial Palsy) 08/2020 - 01/2018
3	Chronic Obstructive Pulmonary Disease (COPD) 11/2019 - 02/2013
3	Dizziness (Lightheadedness) 01/2017 - 01/2015
3	Necrosis 10/2013 - 09/2005
2	Mucinous Adenocarcinoma (Mucinous Carcinoma) 01/2022 - 11/2020
2	Hemorrhage 05/2021 - 07/2012
2	Hearing Loss (Hearing Impairment) 01/2020 - 01/2015
2	Hepatocellular Carcinoma (Hepatoma) 11/2018 - 05/2007
2	Tuberculosis (Tuberculoses) 01/2018 - 05/2009
2	Squamous Cell Carcinoma (Epidermoid Carcinoma) 01/2018 - 04/2012
2	Otitis Media 04/2017 - 10/2013
2	Sudden Hearing Loss (Sudden Deafness) 01/2015 - 01/2014
2	Porcine Reproductive and Respiratory Syndrome (PRRS) 02/2014 - 01/2013
2	Bell Palsy (Bell's Palsy) 04/2013 - 05/2012
1	Facial Asymmetry 01/2022
1	Sjogren's Syndrome (Sjogren Syndrome) 01/2022
1	Systemic Scleroderma (Systemic Sclerosis) 01/2022
1	Ankylosing Spondylitis 01/2022
1	Dermatomyositis (Dermatopolymyositis) 01/2022
1	Connective Tissue Diseases (Connective Tissue Disease) 01/2022
1	Rheumatoid Arthritis 01/2022
1	Systemic Lupus Erythematosus (Libman-Sacks Disease) 01/2022
1	Mixed Connective Tissue Disease (MCTD) 01/2022
1	Polymyositis 01/2022
1	Hematoma 05/2021
1	Pathologic Complete Response 11/2020
1	Diplopia (Double Vision) 06/2020
1	Allergic Rhinitis 03/2020
1	Cysts 01/2019

Drug/Important Bio-Agent (IBA)

16	Biomarkers (Surrogate Marker)IBA 05/2020 - 07/2012
7	SteroidsIBA 01/2020 - 09/2005
6	Tyrosine Kinase InhibitorsIBA 07/2022 - 07/2011
5	ErbB Receptors (EGF Receptor)IBA 01/2022 - 05/2011
5	Immune Checkpoint InhibitorsIBA 01/2021 - 01/2019
4	Pharmaceutical PreparationsIBA 01/2021 - 05/2009
4	CytokinesIBA 03/2014 - 01/2013
3	Dexamethasone (Maxidex)FDA LinkGeneric 12/2019 - 01/2015
3	Fluorodeoxyglucose F18 (Fludeoxyglucose F 18)FDA Link 01/2018 - 04/2010
3	Pattern Recognition ReceptorsIBA 03/2014 - 01/2013
3	InterferonsIBA 03/2014 - 01/2013
3	Messenger RNA (mRNA)IBA 03/2014 - 01/2013
3	Toll-Like Receptors (Toll-Like Receptor)IBA 03/2014 - 01/2013
3	Nitric Oxide Synthase (NO Synthase)IBA 12/2013 - 01/2013
2	Cell-Free Nucleic AcidsIBA 01/2022 - 02/2016
2	Bronchodilator Agents (Bronchodilators)IBA 11/2019 - 12/2013
2	Therapeutic UsesIBA 01/2019 - 01/2015
2	Anti-Bacterial Agents (Antibiotics)IBA 12/2018 - 04/2017
2	DNA (Deoxyribonucleic Acid)IBA 01/2018 - 01/2018
2	IodineIBA 01/2016 - 11/2012
2	Anaplastic Lymphoma KinaseIBA 10/2015 - 01/2015
2	Immunoglobulin A (IgA)IBA 03/2014 - 01/2013
2	InterleukinsIBA 03/2014 - 10/2013
2	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 03/2014 - 01/2013
2	NucleotidesIBA 03/2014 - 01/2013
2	Immunoglobulin M (IgM)IBA 03/2014 - 01/2013
2	Immunoglobulin G (IgG)IBA 03/2014 - 01/2013
2	Interleukin-6 (Interleukin 6)IBA 02/2014 - 10/2013
2	Antiviral Agents (Antivirals)IBA 04/2013 - 05/2012
1	Biological ProductsIBA 11/2022
1	GTP Phosphohydrolases (GTPases)IBA 01/2022
1	Circulating Tumor DNAIBA 01/2022
1	Potassium Iodide (Pima)FDA Link 01/2022
1	beta-cyclodextrin tetradecasulfate (CTDS)IBA 01/2022
1	xylometazoline (stas)IBA 11/2020
1	Carbon MonoxideIBA 01/2020
1	Nimodipine (Modus)FDA LinkGeneric 01/2020
1	pembrolizumabIBA 11/2019
1	Tumor Biomarkers (Tumor Markers)IBA 01/2019
1	N-acetoacetyl-N-deacetylcolchicineIBA 01/2019
1	Levofloxacin (Levaquin)FDA Link 12/2018

Therapy/Procedure

21	Therapeutics 07/2022 - 09/2005
4	Drug Therapy (Chemotherapy) 01/2017 - 10/2010
3	Chemoradiotherapy 11/2020 - 01/2015
3	Precision Medicine 04/2018 - 07/2012
3	Neoadjuvant Therapy 01/2014 - 04/2010
2	Rhinoplasty 01/2022 - 06/2020
2	Radiotherapy 01/2022 - 05/2016
2	Immunotherapy 01/2020 - 03/2019
2	Aftercare (After-Treatment) 01/2019 - 05/2016
2	Transcranial Direct Current Stimulation 01/2019 - 04/2017
2	Thoracotomy 05/2013 - 07/2012
1	Splints (Splint) 05/2021
1	Operative Surgical Procedures 08/2020
1	Tonsillectomy 03/2020
1	Adenoidectomy 03/2020
1	Pneumonectomy (Lung Volume Reduction) 07/2019